Overview: Mucorales Detection TestIntroduction: The Mucorales Detection Test detects Mucorales to diagnose mucormycosis, causing sinus or lung infections. Following 2023 IDSA guidelines, it uses PCR for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in mycology for patients with suspected mucormycosis, often in immunocompromised individuals.
Other Names: Mucorales PCR Assay, Mucormycosis Test.
FDA Status: Laboratory-developed test (LDT), meeting mycology standards for diagnostic accuracy.
Historical Milestone: Mucorales testing began in the 2000s with fungal research. PCR methods improved in the 2010s, enhancing diagnostic precision.
Purpose: Detects Mucorales to diagnose mucormycosis, guides treatment, and evaluates patients with sinus or lung infections.
Test Parameters: 1. Mucorales Species
Pretest Condition: No fasting required. Collect tissue, bronchoalveolar lavage, or sputum. Report history of sinus infections, lung issues, or immunosuppression.
Specimen: Tissue (sterile container, 0.5-2 cma³), Bronchoalveolar Lavage (sterile container, 5-10 mL), Sputum (sterile container, 5-10 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 7 days
Sample Stability at Refrigeration: Not refrigerated
Sample Stability at Frozen: Not frozen
Medical History: Document sinus infections, lung issues, fever, or history of immunosuppression. Include current medications, especially antifungals.
Consent: Written consent required, detailing the tests purpose, mucormycosis implications, and risks of sample collection.
Procedural Considerations: Uses PCR to detect Mucorales species in specimens. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for mucormycosis diagnosis.
Factors Affecting Result Accuracy: Low DNA yield or improper sample storage can affect results. Contamination may reduce specificity.
Clinical Significance: Positive Mucorales detection confirms mucormycosis, guiding antifungal therapy (e.g., amphotericin B). Negative results may require culture testing.
Specialist Consultation: Consult an infectious disease specialist or pulmonologist for result interpretation and treatment planning.
Additional Supporting Tests: Fungal culture, CT imaging, or histopathology to confirm mucormycosis diagnosis.
Test Limitations: Sensitivity depends on sample quality; clinical correlation is needed. Non-Mucorales fungi may complicate interpretation.
References: IDSA Mucormycosis Guidelines, 2023; Clinical Infectious Diseases, Cornely OA, 2022.
